Taizhou, China

Shuai Shen

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Asieris Pharmaceuticals (Shanghai) Co., Ltd., Jiangsu Yahong Meditech Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuai Shen. Retrieved from https://idiyas.com/inventor/shuai-shen-bdkp4qlx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shuai Shen: Innovator in the Medical Field

Introduction

Shuai Shen is an emerging inventor based in Taizhou, China. He has made significant contributions to the medical technology sector, although he currently holds no patents. His work reflects a commitment to advancing healthcare solutions.

Latest Patents

As of now, Shuai Shen has not registered any patents. This may change as he continues to develop his ideas and innovations in the medical field.

Career Highlights

Shuai Shen has worked with notable companies such as Jiangsu Yahong Meditech Co., Ltd. and Asieris Pharmaceuticals (Shanghai) Co., Ltd. His experience in these organizations has provided him with valuable insights into the medical technology industry.

Collaborations

Shuai has collaborated with professionals like Jie Chen and Haiyan Li. These partnerships have likely enriched his work and contributed to his understanding of innovative medical solutions.

Conclusion

Shuai Shen is a promising inventor in the medical field, with a focus on developing innovative solutions. His career is still in its early stages, and it will be interesting to see how his contributions evolve in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…